CancerWorld Issue #110 (December) is Live
25 Posts Not to Miss from ASH 2025
Paco Arango: "Casa Aladina" - the First Comprehensive Support Day Center in Europe for Children with Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Final Results of CARES-310 Study: Camrelizumab + Rivoceranib vs Sorafenib in Unresectable HCC
Prof. Ruben Mesa Recognized with the 2025 ASH Ernest Beutler Lecture and Prize
MajesTEC-3 trial: Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Alicia Zhou: The Mission-Driven Biologist Building the Future of Immunotherapy
